Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02073734 · ClinicalTrials.gov registry record · Phase 3
Effects of Preoperative Dexamethasone Study on QOL After Vaginal Reconstructive Surgery for POP
A Phase 3 study of Pelvic Organ Prolapse and PONV, sponsored by TriHealth.
- Completed
- Registry status
- Phase 3
- Development phase
- 63
- Enrollment target
- 1
- Study location
NCT02073734: Completed Phase 3 study of Pelvic Organ Prolapse and PONV, sponsored by TriHealth.
NCT02073734 is a Phase 3 study of Pelvic Organ Prolapse and PONV that has completed, run by TriHealth. The registered enrollment target is 63 participants, below the 144-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02073734, a Phase 3 study of Pelvic Organ Prolapse and PONV, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators hypothesize that preoperative administration of 8 mg IV dexamethasone will benefit patients' perceived quality of recovery after surgery.
Primary Outcome
The QoR-40 is a validated standardized questionnaire that assesses the dimensions of physical functioning, mental health, cognitive functioning, symptoms, role and social functioning, general health perceptions, sleep and energy
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Dexamethasone
Study Locations (1)
Ohio
- Triheath - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-08 |
| Phase | Phase 3 |
What the finished NCT02073734 record still lists
NCT02073734 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 144-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (56% lower).
The record links to 2 conditions, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02073734 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02073734 about?
NCT02073734 is a clinical study titled "Effects of Preoperative Dexamethasone Study on QOL After Vaginal Reconstructive Surgery for POP". The investigators hypothesize that preoperative administration of 8 mg IV dexamethasone will benefit patients' perceived quality of recovery after surgery.
What is the current status of trial NCT02073734?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 63 participants. The study started on 2013-02. Estimated completion is 2014-08.
What conditions does trial NCT02073734 study?
This clinical trial studies the following conditions: Pelvic Organ Prolapse, PONV.
What interventions are being tested in trial NCT02073734?
The interventions under investigation include: Placebo (DRUG), Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT02073734?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02073734 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Organ Prolapse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02073734's enrollment target sits among peer trials
63 32nd of 40 higher than 8 of 40 other Pelvic Organ Prolapse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pelvic Organ Prolapse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lidocaine for Pessary Check Pain Reduction
COMPLETED · Phase 3
-
Centered Surgery - Preoperative Counseling and Patient Satisfaction
RECRUITING
-
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
RECRUITING
-
Pessary Experience Study
RECRUITING
-
SORE Study: Sitz Baths After Urogynecologic Reconstruction
RECRUITING · NA
-
POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia